Skip to main content
TipRanks
Go Ultimate75% OFF

John Crues Insider Profile

4 Followers

John Crues, Medical Director, Director at Radnet, holds 435.26K shares in Radnet (Ticker: RDNT). Most recently, John Crues Sold 10,000 shares of Radnet on Mar 16, 2021 for an estimated value of $238.20K.

John Crues's Trading History

RDNT
Radnet
Mar 16, 2021Medical Director, DirectorInformative Sell238.20K$33.26M
RDNT
Insider Shares: 435.26K (0.83%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 16, 2021Informative Sell$238.20K10,000$23.82+5.30%
Jan 06, 2021Uninformative Buy$0.0015,847$0.00―
Jan 28, 2020Uninformative Buy$0.0015,318$0.00―
Nov 18, 2019Informative Sell$360.20K20,000$18.01-2.10%
Nov 15, 2019Informative Sell$316.80K20,000$15.84-3.40%

You May Also Like

John Crues insider profile FAQ

What is the percentage of profitable transactions made by John Crues?
The percentage of profitable transactions made by John Crues is 25%.
What is the average return per transaction made by John Crues?
The average return per transaction made by John Crues is -6.90%.
What stocks does John Crues hold?
John Crues holds: RDNT stocks.
What was John Crues’s latest transaction?
John Crues’s latest transaction was an Informative Sell of $238.20K.
What was John Crues's most profitable transaction?
John Crues’s most profitable transaction was an Informative Sell of RDNT stock on June 5, 2015. The return on the trade was 21.10%.
What is John Crues's role in Radnet?
John Crues's role in Radnet is Medical Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.